Какова цена за Asensus Surgical, Inc. (ASXC)

Цена за Asensus Surgical, Inc. (ASXC) Это $0.3479

Какова рыночная капитализация для Asensus Surgical, Inc. (ASXC)

Рыночная капитализация для Asensus Surgical, Inc. (ASXC) Это $94.92M

Прибыль Asensus Surgical, Inc. (ASXC)

Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.

Год	Прибыль	Изменить
2026 (TTM)	$-83.44M	6.82%
2023	$-78.12M	3.82%
2022	$-75.24M	20.90%
2021	$-62.24M	2.32%
2020	$-60.83M	-61.34%
2019	$-157.33M	141.47%
2018	$-65.15M	-56.01%
2017	$-148.10M	18.00%
2016	$-125.50M	161.62%
2015	$-47.97M	27.41%
2014	$-37.65M	32.77%
2013	$-28.36M	83.84%
2012	$-15.43M	167.89%
2011	$-5.76M	8.58%
2010	$-5.30M	124.13%
2009	$-2.37M	-54.37%
2008	$-5.19M	70.50%
2007	$-3.04M	1,390.69%
2006	$-204.00K	-10.53%
2005	$-228.00K	-48.65%
2004	$-444.00K	-54.04%
2003	$-966.00K	-82.05%
2002	$-5.38M	-997.00%
2001	$600.00K	-77.01%
2000	$2.61M	0.00%

Год

Прибыль

Изменить

2026 (TTM)

$-83.44M

6.82%

2023

$-78.12M

3.82%

2022

$-75.24M

20.90%

2021

$-62.24M

2.32%

2020

$-60.83M

-61.34%

2019

$-157.33M

141.47%

2018

$-65.15M

-56.01%

2017

$-148.10M

18.00%

2016

$-125.50M

161.62%

2015

$-47.97M

27.41%

2014

$-37.65M

32.77%

2013

$-28.36M

83.84%

2012

$-15.43M

167.89%

2011

$-5.76M

8.58%

2010

$-5.30M

124.13%

2009

$-2.37M

-54.37%

2008

$-5.19M

70.50%

2007

$-3.04M

1,390.69%

2006

$-204.00K

-10.53%

2005

$-228.00K

-48.65%

2004

$-444.00K

-54.04%

2003

$-966.00K

-82.05%

2002

$-5.38M

-997.00%

2001

$600.00K

-77.01%

2000

$2.61M

0.00%

Компания	Прибыль	Разница в прибыли	Страна
Abbott Laboratories ABT.US	$7.51B	-9,101.35%	US
Stryker Corporation SYK.US	$5.15B	-6,269.48%	US
Medtronic plc MDT.US	$5.56B	-6,766.83%	IE
Boston Scientific Corporation BSX.US	$3.86B	-4,727.11%	US
Siemens Healthineers AG SHL.DE	-	-	DE

Компания

Прибыль

Разница в прибыли

Страна